Global aberrant splicing has been reported in many diseases including benign and malignant disorders, such as cystic fibrosis, Alzheimer disease and many cancers, as well as AML2,5,6,25,26. This evidence concerns the gene RUNX3 and early-onset autosomal dominant Alzheimer disease.